Hong Kong
· Delayed Price · Currency is HKD LifeTech Scientific Company Description
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide.
The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments.
Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers.
The company is also involved in the biomedical research and development; properties leasing business; and manufacturing and trading of medical devices, as well as offers technical, consulting, and technology services.
The company was founded in 1999 and is headquartered in Shenzhen, China.
| Country | Cayman Islands |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,448 |
| CEO | Yuehui Xie |
Contact Details
Address: LifeTech Scientific Building Shenzhen, 518063 China | |
| Phone | 86 75 5860 26250 |
| Website | lifetechmed.com |
Stock Details
| Ticker Symbol | 1302 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG548721177 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Yuehui Xie | Chairman and Chief Executive Officer |
| Jianxiong Liu ACCA | Chief Financial Officer, Executive Vice President, Company Secretary and Executive Director |